Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD24hiCD38hi transitional B cells and CD9 as new biomarker of long-term human lung allograft survival

CD24hiCD38hi transitional B cells and CD9 as new biomarker of long-term human lung allograft survival

US Patent 11761960 · Granted Sep 19, 2023

Estimated economic value: $175,256,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for treating asthma and allergic diseases2025
Methods and compositions for predicting chronic lung allograft dysfunction2023
Methods and compositions for predicting chronic lung allograft dysfunction2023
Methods for discriminating a tolerant subject2022
Methods and compositions for predicting chronic lung allograft dysfunction2022
Methods and compositions for predicting chronic lung allograft dysfunction2022
Methods and compositions for predicting chronic lung allograft dysfunction2021
Methods and compositions for predicting chronic lung allograft dysfunction2021
Methods for predicting graft alterations2021
RAC1 inhibitors for inducing bronchodilation2018
Antibodies directed against the alpha chain of IL7 receptor—their use for the pr2016
Methods and compositions for determining a graft tolerant phenotype in a subject2015